Agency Information Collection Activities: Submission for OMB Review; Comment Request, 50799-50800 [E9-23707]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 189 / Thursday, October 1, 2009 / Notices
(NIOSH), Department of Health and
Human Services (HHS).
ACTION: Notice.
SUMMARY: HHS gives notice as required
by 42 CFR 83.12(e) of a decision to
evaluate a petition to designate a class
of employees for the Hanford site in
Richland, Washington, to be included in
the Special Exposure Cohort under the
Energy Employees Occupational Illness
Compensation Program Act of 2000. The
initial proposed definition for the class
being evaluated, subject to revision as
warranted by the evaluation, is as
follows:
Facility: Hanford site.
Location: Richland, Washington.
Job Titles and/or Job Duties: All
employees of the Department of Energy,
its predecessor agencies, and its
contractors and subcontractors.
Period of Employment: October 1,
1943 through June 30, 1972.
FOR FURTHER INFORMATION CONTACT:
Larry Elliott, Director, Office of
Compensation Analysis and Support,
National Institute for Occupational
Safety and Health (NIOSH), 4676
Columbia Parkway, MS C–46,
Cincinnati, OH 45226, Telephone
513–533–6800 (this is not a toll-free
number). Information requests can also
be submitted by e-mail to
OCAS@CDC.GOV.
John Howard,
Director, National Institute for Occupational
Safety and Health.
[FR Doc. E9–23686 Filed 9–30–09; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–10237 and CMS–
10137]
PWALKER on DSK8KYBLC1PROD with NOTICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
VerDate Nov<24>2008
19:32 Sep 30, 2009
Jkt 217001
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Medicare
Advantage Applications-Part C ; Use:
Under section 1851(a)(1) of the Social
Security Act, every individual entitled
to Medicare Part A and enrolled under
Part B, except for most individuals with
end-stage renal disease (ESRD), could
elect to receive benefits either through
the Original Medicare Program or an
M+C plan, if one was offered where he
or she lived. The Medicare Prescription
Drug, Improvement, and Modernization
Act of 2003 (MMA) Public Law 108–173
was enacted on December 8, 2003. The
MMA established the Medicare
Prescription Drug Benefit Program (Part
D) and made revisions to the provisions
of Medicare Part C, governing what is
now called the Medicare Advantage
(MA) program (formerly
Medicare+Choice). The MMA was
amended on July 15, 2008 by the
enactment of the Medicare
Improvements for Patients and
Providers Act of 2008 (MIPPA).
Coverage for the prescription drug
benefit is provided through contracted
prescription drug plans or through
Medicare Advantage (MA) plans that
offer integrated prescription drug and
health care coverage (MA–PD plans).
Cost plans that are required under
section 1876 of the Social Security Act,
and Employer Group Waiver Plans
(EGWP) may also provide a Part D
benefit. Organizations wishing to
provide services under the MA and
MA–PD plans must complete an
application, negotiate rates and receive
final approval from CMS. Certain
existing MA plans may also expand
their contracted area by completing the
Service Area Expansion (SAE)
application. Health plans must meet
regulatory requirements to enter into a
contract with CMS in order to provide
health benefits to Medicare
beneficiaries. The revised MA
applications are the collection
receptacles required. Refer to the
supporting document- High-Level
Summary of All Part C Application
Revisions- for a list of changes: Form
Number: CMS–10237 (OMB#: 0938–
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
50799
0935); Frequency: Reporting—Yearly;
Affected Public: Business or other forprofits and not-for-profit institutions;
Number of Respondents: 291; Total
Annual Responses: 291; Total Annual
Hours: 9547. (For policy questions
regarding this collection contact Letticia
Ramsey at 410–786–5262. For all other
issues call 410–786–1326.)
2. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Application for
Prescription Drug Plans (PDP);
Application for Medicare Advantage
Prescription Drug (MA–PD);
Application for Cost Plans to Offer
Qualified Prescription Drug Coverage;
Application for Employer Group Waiver
Plans to Offer Prescription Drug
Coverage; Service Area Expansion
Application for Prescription Drug
Coverage; Use: The Medicare
Prescription Drug Benefit program was
established by section 101 of the
Medicare Prescription Drug,
Improvement, and Modernization Act of
2003 (MMA) and is codified in section
1860D of the Social Security Act (the
Act). Section 101 of the MMA amended
Title XVIII of the Social Security Act by
redesignating Part D as Part E and
inserting a new Part D, which
establishes the voluntary Prescription
Drug Benefit Program (‘‘Part D’’). The
MMA was amended on July 15, 2008 by
the enactment of the Medicare
Improvements for Patients and
Providers Act of 2008 (MIPPA).
Coverage for the prescription drug
benefit is provided through contracted
prescription drug plans (PDPs) or
through Medicare Advantage (MA)
plans that offer integrated prescription
drug and health care coverage (MA–PD
plans). Cost Plans that are regulated
under Section 1876 of the Social
Security Act, and Employer Group
Waiver Plans (EGWP) may also provide
a Part D benefit. Organizations wishing
to provide services under the
Prescription Drug Benefit Program must
complete an application, negotiate rates
and receive final approval from CMS.
Existing Part D sponsors may also
expand their contracted service area by
completing the Service Area Expansion
(SAE) application. Refer to supporting
document ‘‘Summary of Substantive
and Technical Changes for All Part D
Application Revisions from 2010
Version of Part D application to 2011
Draft Version’’: Form Number: CMS–
10137 (OMB#: 0938–0936); Frequency:
Reporting—Once; Affected Public:
Business or other for-profits and Notfor-profit institutions; Number of
Respondents: 453; Total Annual
Responses: 453; Total Annual Hours:
E:\FR\FM\01OCN1.SGM
01OCN1
50800
Federal Register / Vol. 74, No. 189 / Thursday, October 1, 2009 / Notices
11,919. (For policy questions regarding
this collection contact Marla Rothouse
at 410–786–8063. For all other issues
call 410–786–1326.)
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS Web site
address at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or
E-mail your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
To be assured consideration,
comments and recommendations for the
proposed information collections must
be received by the OMB desk officer at
the address below, no later than 5 p.m.
on November 2, 2009.
OMB, Office of Information and
Regulatory Affairs,
Attention: CMS Desk Officer.
Fax Number: (202) 395–6974.
E-mail:
OIRA_submission@omb.eop.gov.
Dated: September 24, 2009.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E9–23707 Filed 9–30–09; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–09–08AU]
Agency Forms Undergoing Paperwork
Reduction Act Review
The Centers for Disease Control and
Prevention (CDC) publishes a list of
information collection requests under
review by the Office of Management and
Budget (OMB) in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written
comments to CDC Desk Officer, Office of
Management and Budget, Washington,
DC or by fax to (202) 395–5806. Written
comments should be received within 30
days of this notice.
Proposed Project
Assessing Problem Areas in Referrals
for Chronic Hematologic Malignancies
and Developing Interventions to
Address Them—New—Division of
Cancer Prevention and Control (DCPC),
National Center for Chronic Disease
Prevention and Health Promotion
(NCCDPHP), Centers for Disease Control
and Prevention (CDC).
Background and Brief Description
Despite the advent of new diagnostics
and therapeutics for patients with
chronic hematological malignancies,
data from the United States, Europe and
Canada allude to a problem of timely
referral and diagnosis for patients with
cancer. Improving the timeliness of care
and referral to appropriate specialists
are key health care quality objectives.
CDC proposes to conduct a one-time
study to collect qualitative and
quantitative information on optimal and
suboptimal referral patterns for patients
with confirmed or suspected chronic
hematologic malignancies. Information
will be collected to identify specific
factors related to delays in diagnosis
and/or referral to appropriate medical
specialists. Information will be collected
through in-depth interviews with
hematologic cancer patients, in-depth
interviews and focus groups with
primary care providers, interviews with
specialists in hematology and oncology,
and a one-time postal survey to a
sample of primary care providers (PCP).
The PCP survey may be completed in
paper form or via the Web.
The ultimate goal is to develop tools
that will improve the awareness,
diagnosis, and referral of persons with
chronic hematological cancers by
primary care providers.
There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
198.
ESTIMATED ANNUALIZED BURDEN HOURS
No. of
respondents
Type of respondents
Form name
Community Hematologists/Oncologists ..........
Community Hematologists and Oncologists
Interview Phone Recruitment Script.
Community Hematologists and Oncologists
Interview Guide.
Patient Interview Phone Recruitment Script ..
Patient Interview Guide ..................................
PCP Survey Cover Letter ...............................
PCP Survey ....................................................
PCP Opt-Out Card .........................................
PCP Survey Reminder Letter .........................
PCP Interview Phone Recruitment Script ......
PCP Interview Guide ......................................
PCP Focus Group Phone Recruitment Script
PCP Focus Group Guide ...............................
Patients ...........................................................
PWALKER on DSK8KYBLC1PROD with NOTICES
Primary Care Providers (PCP) .......................
VerDate Nov<24>2008
19:32 Sep 30, 2009
Jkt 217001
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
E:\FR\FM\01OCN1.SGM
No. of
responses per
respondent
Average
burden per
response
(in hours)
100
1
2/60
18
1
1.5
50
18
250
150
100
200
100
18
50
18
1
1
1
1
1
1
1
1
1
1
2/60
1.5
2/60
20/60
2/60
2/60
3/60
1.5
3/60
2
01OCN1
]]>Agencies
[Federal Register Volume 74, Number 189 (Thursday, October 1, 2009)]
[Notices]
[Pages 50799-50800]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23707]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[Document Identifier: CMS-10237 and CMS-10137]
Agency Information Collection Activities: Submission for OMB
Review; Comment Request
AGENCY: Centers for Medicare & Medicaid Services, HHS.
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid
Services (CMS), Department of Health and Human Services, is publishing
the following summary of proposed collections for public comment.
Interested persons are invited to send comments regarding this burden
estimate or any other aspect of this collection of information,
including any of the following subjects: (1) The necessity and utility
of the proposed information collection for the proper performance of
the Agency's function; (2) the accuracy of the estimated burden; (3)
ways to enhance the quality, utility, and clarity of the information to
be collected; and (4) the use of automated collection techniques or
other forms of information technology to minimize the information
collection burden.
1. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Medicare
Advantage Applications-Part C ; Use: Under section 1851(a)(1) of the
Social Security Act, every individual entitled to Medicare Part A and
enrolled under Part B, except for most individuals with end-stage renal
disease (ESRD), could elect to receive benefits either through the
Original Medicare Program or an M+C plan, if one was offered where he
or she lived. The Medicare Prescription Drug, Improvement, and
Modernization Act of 2003 (MMA) Public Law 108-173 was enacted on
December 8, 2003. The MMA established the Medicare Prescription Drug
Benefit Program (Part D) and made revisions to the provisions of
Medicare Part C, governing what is now called the Medicare Advantage
(MA) program (formerly Medicare+Choice). The MMA was amended on July
15, 2008 by the enactment of the Medicare Improvements for Patients and
Providers Act of 2008 (MIPPA).
Coverage for the prescription drug benefit is provided through
contracted prescription drug plans or through Medicare Advantage (MA)
plans that offer integrated prescription drug and health care coverage
(MA-PD plans). Cost plans that are required under section 1876 of the
Social Security Act, and Employer Group Waiver Plans (EGWP) may also
provide a Part D benefit. Organizations wishing to provide services
under the MA and MA-PD plans must complete an application, negotiate
rates and receive final approval from CMS. Certain existing MA plans
may also expand their contracted area by completing the Service Area
Expansion (SAE) application. Health plans must meet regulatory
requirements to enter into a contract with CMS in order to provide
health benefits to Medicare beneficiaries. The revised MA applications
are the collection receptacles required. Refer to the supporting
document- High-Level Summary of All Part C Application Revisions- for a
list of changes: Form Number: CMS-10237 (OMB: 0938-0935);
Frequency: Reporting--Yearly; Affected Public: Business or other for-
profits and not-for-profit institutions; Number of Respondents: 291;
Total Annual Responses: 291; Total Annual Hours: 9547. (For policy
questions regarding this collection contact Letticia Ramsey at 410-786-
5262. For all other issues call 410-786-1326.)
2. Type of Information Collection Request: Revision of a currently
approved collection; Title of Information Collection: Application for
Prescription Drug Plans (PDP); Application for Medicare Advantage
Prescription Drug (MA-PD); Application for Cost Plans to Offer
Qualified Prescription Drug Coverage; Application for Employer Group
Waiver Plans to Offer Prescription Drug Coverage; Service Area
Expansion Application for Prescription Drug Coverage; Use: The Medicare
Prescription Drug Benefit program was established by section 101 of the
Medicare Prescription Drug, Improvement, and Modernization Act of 2003
(MMA) and is codified in section 1860D of the Social Security Act (the
Act). Section 101 of the MMA amended Title XVIII of the Social Security
Act by redesignating Part D as Part E and inserting a new Part D, which
establishes the voluntary Prescription Drug Benefit Program (``Part
D''). The MMA was amended on July 15, 2008 by the enactment of the
Medicare Improvements for Patients and Providers Act of 2008 (MIPPA).
Coverage for the prescription drug benefit is provided through
contracted prescription drug plans (PDPs) or through Medicare Advantage
(MA) plans that offer integrated prescription drug and health care
coverage (MA-PD plans). Cost Plans that are regulated under Section
1876 of the Social Security Act, and Employer Group Waiver Plans (EGWP)
may also provide a Part D benefit. Organizations wishing to provide
services under the Prescription Drug Benefit Program must complete an
application, negotiate rates and receive final approval from CMS.
Existing Part D sponsors may also expand their contracted service area
by completing the Service Area Expansion (SAE) application. Refer to
supporting document ``Summary of Substantive and Technical Changes for
All Part D Application Revisions from 2010 Version of Part D
application to 2011 Draft Version'': Form Number: CMS-10137
(OMB: 0938-0936); Frequency: Reporting--Once; Affected Public:
Business or other for-profits and Not-for-profit institutions; Number
of Respondents: 453; Total Annual Responses: 453; Total Annual Hours:
[[Page 50800]]
11,919. (For policy questions regarding this collection contact Marla
Rothouse at 410-786-8063. For all other issues call 410-786-1326.)
To obtain copies of the supporting statement and any related forms
for the proposed paperwork collections referenced above, access CMS Web
site address at https://www.cms.hhs.gov/PaperworkReductionActof1995, or
E-mail your request, including your address, phone number, OMB number,
and CMS document identifier, to Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786-1326.
To be assured consideration, comments and recommendations for the
proposed information collections must be received by the OMB desk
officer at the address below, no later than 5 p.m. on November 2, 2009.
OMB, Office of Information and Regulatory Affairs,
Attention: CMS Desk Officer.
Fax Number: (202) 395-6974.
E-mail: OIRA_submission@omb.eop.gov.
Dated: September 24, 2009.
Michelle Shortt,
Director, Regulations Development Group, Office of Strategic Operations
and Regulatory Affairs.
[FR Doc. E9-23707 Filed 9-30-09; 8:45 am]
BILLING CODE 4120-01-P
